Prot #MLS-101-206: A Phase 2 Study to Evaluate the Efficacy and Safety of Lorundrostat Alone, and Lorundostat in Combination with Dapagliflozin, in Adults with Hypertension and Chronic Kidney Disease with Albuminuria